Stephen Blake

Stephen Blake is a Senior Postdoctoral Fellow at the Precision Cancer Medicine Theme of the South Australian Health and Medical Research Institute (SAHMRI) and an academic status holder at Flinders University's College of Medicine and Public Health. His work spans cancer immunotherapy and microbiome-immune interactions, with 30 publications (14 as first/senior author) and over 2,230 citations.

• PhD, University of Adelaide, 2009
• BSc (Honours), University of Adelaide, 2004
• BSc (Biomedical Science), University of Adelaide, 2003

Blake’s research focuses on:

• Cancer immunotherapy mechanisms (siRNA, TLR7, PD-1 blockade)
• Gut microbiota influence on therapy efficacy and toxicity
• Microbiome-immune crosstalk in vaccine responses and aging

Key publication trends show strong emphasis on microbiome-immune interactions (2021-2025), with earlier work on NK cells and tumor immunology (2008-2016). Collaborations with institutions like EMBL Australia and QIMR Berghofer are central to his work.

• Scientific Awards: University of Queensland ECR Fellowship

Blake supervises research in Medical Biosciences and contributes to SDG 3 (Good Health) through microbiome and cancer therapy studies. His work with the Lynn Group at SAHMRI highlights systems immunology approaches.